Intensity-Modulated and Image-Guided Radiation Therapy

[1]  Di Yan,et al.  Potential for reduced toxicity and dose escalation in the treatment of inoperable non-small-cell lung cancer: a comparison of intensity-modulated radiation therapy (IMRT), 3D conformal radiation, and elective nodal irradiation. , 2003, International journal of radiation oncology, biology, physics.

[2]  T. Holmes,et al.  American Society of Radiation Oncology recommendations for documenting intensity-modulated radiation therapy treatments. , 2009, International journal of radiation oncology, biology, physics.

[3]  K. Otto,et al.  A comparison of volumetric modulated arc therapy and conventional intensity-modulated radiotherapy for frontal and temporal high-grade gliomas. , 2010, International journal of radiation oncology, biology, physics.

[4]  S. Kannan,et al.  Effect of imaging frequency on PTV margins and geographical miss during image guided radiation therapy for prostate cancer. , 2017, Practical radiation oncology.

[5]  Radhe Mohan,et al.  Influence of technologic advances on outcomes in patients with unresectable, locally advanced non-small-cell lung cancer receiving concomitant chemoradiotherapy. , 2010, International journal of radiation oncology, biology, physics.

[6]  Emma Hall,et al.  Parotid-sparing intensity modulated versus conventional radiotherapy in head and neck cancer (PARSPORT): a phase 3 multicentre randomised controlled trial , 2011, The Lancet. Oncology.

[7]  Jaw-Yuan Wang,et al.  A retrospective comparison of outcome and toxicity of preoperative image-guided intensity-modulated radiotherapy versus conventional pelvic radiotherapy for locally advanced rectal carcinoma , 2016, Journal of radiation research.

[8]  K. Haustermans,et al.  IMRT-based optimization approaches for volumetric modulated single arc radiotherapy planning. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[9]  Ying Sun,et al.  Clinical Outcomes of Volume-Modulated Arc Therapy in 205 Patients with Nasopharyngeal Carcinoma: An Analysis of Survival and Treatment Toxicities , 2015, PloS one.

[10]  M. V. van Herk,et al.  The probability of correct target dosage: dose-population histograms for deriving treatment margins in radiotherapy. , 2000, International journal of radiation oncology, biology, physics.

[11]  Jeffrey V Siebers,et al.  Effect of patient setup errors on simultaneously integrated boost head and neck IMRT treatment plans. , 2005, International journal of radiation oncology, biology, physics.

[12]  T. Bortfeld,et al.  Methods of image reconstruction from projections applied to conformation radiotherapy. , 1990, Physics in medicine and biology.

[13]  Patrice Jalade,et al.  Potential benefits of using non coplanar field and intensity modulated radiation therapy to preserve the heart in irradiation of lung tumors in the middle and lower lobes. , 2006, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[14]  Y. Yamada,et al.  Incidence of late rectal and urinary toxicities after three-dimensional conformal radiotherapy and intensity-modulated radiotherapy for localized prostate cancer. , 2008, International journal of radiation oncology, biology, physics.

[15]  F. Lohr,et al.  Volumetric modulated arc therapy (VMAT) vs. serial tomotherapy, step-and-shoot IMRT and 3D-conformal RT for treatment of prostate cancer. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  Hilke Vorwerk,et al.  Radiotherapy of malignant gliomas: comparison of volumetric single arc technique (RapidArc), dynamic intensity-modulated technique and 3D conformal technique. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[17]  Michael B Sharpe,et al.  Image-guided radiotherapy: rationale, benefits, and limitations. , 2006, The Lancet. Oncology.

[18]  Michael J. Zelefsky,et al.  High-dose intensity modulated radiation therapy for prostate cancer: early toxicity and biochemical outcome in 772 patients. , 2002, International journal of radiation oncology, biology, physics.

[19]  Pietro Mancosu,et al.  Phase I-II study of hypofractionated simultaneous integrated boost using volumetric modulated arc therapy for adjuvant radiation therapy in breast cancer patients: a report of feasibility and early toxicity results in the first 50 treatments , 2012, Radiation Oncology.

[20]  Karl Otto,et al.  Volumetric modulated arc therapy: IMRT in a single gantry arc. , 2007, Medical physics.

[21]  K. Otto,et al.  Volumetric modulated arc therapy for delivery of prostate radiotherapy: comparison with intensity-modulated radiotherapy and three-dimensional conformal radiotherapy. , 2008, International journal of radiation oncology, biology, physics.

[22]  M. Matuszak,et al.  Inverse-optimized 3D conformal planning: minimizing complexity while achieving equivalence with beamlet IMRT in multiple clinical sites. , 2012, Medical physics.

[23]  Maria T. Vlachaki,et al.  Intensity modulated radiation therapy versus three‐dimensional conformal radiation therapy for the treatment of high grade glioma: a dosimetric comparison , 2007, Journal of applied clinical medical physics.

[24]  E. Hall,et al.  Intensity-modulated radiation therapy, protons, and the risk of second cancers. , 2006, International journal of radiation oncology, biology, physics.

[25]  S. Nuyts,et al.  Clinical and dosimetric evaluation of RapidArc versus standard sliding window IMRT in the treatment of head and neck cancer , 2014, Strahlentherapie und Onkologie.

[26]  Ke Sheng,et al.  Comparison of Elekta VMAT with helical tomotherapy and fixed field IMRT: plan quality, delivery efficiency and accuracy. , 2010, Medical physics.

[27]  M. Parmar,et al.  Escalated-dose versus standard-dose conformal radiotherapy in prostate cancer: first results from the MRC RT01 randomised controlled trial. , 2007, The Lancet. Oncology.

[28]  Fang-Fang Yin,et al.  Radiotherapy treatment plans with RapidArc for prostate cancer involving seminal vesicles and lymph nodes. , 2010, International journal of radiation oncology, biology, physics.

[29]  C. Ménard,et al.  Improved outcomes with dose escalation in localized prostate cancer treated with precision image-guided radiotherapy. , 2017, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[30]  Richard Shaffer,et al.  Volumetric modulated arc therapy improves dosimetry and reduces treatment time compared to conventional intensity-modulated radiotherapy for locoregional radiotherapy of left-sided breast cancer and internal mammary nodes. , 2010, International journal of radiation oncology, biology, physics.

[31]  Pietro Mancosu,et al.  Phase II trial of hypofractionated VMAT-based treatment for early stage breast cancer: 2-year toxicity and clinical results , 2016, Radiation Oncology.

[32]  W. De Gersem,et al.  Radiotherapy of prostate cancer with or without intensity modulated beams: a planning comparison. , 2000, International journal of radiation oncology, biology, physics.

[33]  M. Scorsetti,et al.  Early clinical experience with volumetric modulated arc therapy in head and neck cancer patients , 2010, Radiation oncology.

[34]  D. Amelio,et al.  Intensity-modulated radiation therapy in newly diagnosed glioblastoma: a systematic review on clinical and technical issues. , 2010, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[35]  P. Gutin,et al.  Intensity modulated radiotherapy in high grade gliomas: Clinical and dosimetric results. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[36]  Kyubo Kim,et al.  Two-year Follow-up of Volumetric-modulated Arc Therapy for Treating Internal Mammary Nodes in Locally Advanced Breast Cancer. , 2016, Anticancer research.

[37]  A. Nichol,et al.  Coplanar versus noncoplanar intensity‐modulated radiation therapy (IMRT) and volumetric‐modulated arc therapy (VMAT) treatment planning for fronto‐temporal high‐grade glioma† , 2012, Journal of applied clinical medical physics.

[38]  Suresh Senan,et al.  Volumetric intensity-modulated arc therapy vs. conventional IMRT in head-and-neck cancer: a comparative planning and dosimetric study. , 2009, International journal of radiation oncology, biology, physics.

[39]  J. Lebesque,et al.  Late Side Effects After Image Guided Intensity Modulated Radiation Therapy Compared to 3D-Conformal Radiation Therapy for Prostate Cancer: Results From 2 Prospective Cohorts. , 2016, International journal of radiation oncology, biology, physics.

[40]  Marnix G Witte,et al.  Acute toxicity after image-guided intensity modulated radiation therapy compared to 3D conformal radiation therapy in prostate cancer patients. , 2015, International journal of radiation oncology, biology, physics.

[41]  M A Earl,et al.  An arc-sequencing algorithm for intensity modulated arc therapy. , 2007, Medical physics.

[42]  Thomas Guerrero,et al.  Dose and volume reduction for normal lung using intensity-modulated radiotherapy for advanced-stage non-small-cell lung cancer. , 2004, International journal of radiation oncology, biology, physics.

[43]  Luca Cozzi,et al.  Volumetric modulated arc radiotherapy for carcinomas of the oro-pharynx, hypo-pharynx and larynx: a treatment planning comparison with fixed field IMRT. , 2009, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[44]  Michael J. Zelefsky,et al.  Long-term survival and toxicity in patients treated with high-dose intensity modulated radiation therapy for localized prostate cancer. , 2013, International journal of radiation oncology, biology, physics.

[45]  Radhe Mohan,et al.  Initial evaluation of treatment-related pneumonitis in advanced-stage non-small-cell lung cancer patients treated with concurrent chemotherapy and intensity-modulated radiotherapy. , 2007, International journal of radiation oncology, biology, physics.